An acute or persistent joint infection is known as arthritis, and it may cause a huge variety of symptoms, along with pain, stiffness, a decrease in the variety of motion, and joint abnormalities. The kinds of arthritis, i.e., rheumatoid arthritis (RA) and osteoarthritis had been mentioned in this article. In RA patients, infection was caused by means of pro-inflammatory cytokines like IL-1, IL-6, IL-8, and IL-10. Nonsteroidal anti-inflammatory medications (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and a few biological agents are the most popular RA remedies. However, not one of the remedies available is capable of attaining the final purpose for treating, i.e., drug-free remission. Microemulsions, microspheres, micelles, liposomes, microballoons, co-crystals, nanoemulsions, dendrimers, microsponges, and different strategies had been employed for intrasynovial medicine administration. Because of their size and chemical composition, liposomes have been demonstrated to be specifically effective for maintaining the drugs in the synovial cavity. In contrast to present drugs, novel nanotherapeutic strategies have proven greater selective targeting, extended half-life, subtle bioavailability, and decreased systemic toxicity with the use of nanomaterials and sensible nanomedicines. <!----> <!----> <!----> <!---->